Agenda

MPE 10th Anniversary and Masterclass 2021 agenda

2 – 3 July 2021 – Virtual meeting

Friday, 2 July 2021

13:00 – 13:30	Welcome
	Opening Remarks, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO
13.30 – 15.00	Updates in Multiple Myeloma Diagnosis and Treatment
	The early detection and diagnosis of MGUS and SMM, Marivi Mateos, MD, PhD, Director of the Myeloma Unit at the University Hospital of Salamanca-IBSAL, Spain
	New developments and controversies in the myeloma treatment pathway, Mohamad Mohty, MD, PhD, Head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital at University Pierre and Marie Curie, Paris, France
	Moderated Q&A
15.00 – 15.15	Coffee Break
15.15 – 16.45	Multiple myeloma patients and patient organizations in the time of COVID-19
	COVID-19 and the effect on the treatment and care for myeloma and AL amyloidosis patients in Europe, Mohamad Mohty
	MPE members response to and resiliency during COVID-19, MPE Member Organizations
	Moderated Q&A
16.45 – 17.00	Wrap-up, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO
17:00 – 17:30	Coffee Break
17:30 – 18:30	MPE 10^th Anniversary Happy Hour! Join us as we cheers to 10 years of MPE, celebrate all that we’ve achieved together, and enjoy a live show from renowned mind reader, Ashley Green! Please note that this is open to MPE members and invited guests only.

Saturday, 3 July 2021

9:00 – 9:15	Welcome
	Opening Remarks, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO
9.15 – 10.45	AL Amyloidosis & other MM related diseases
	Developments in AL amyloidosis: diagnostic centres of expertise, treatment pathway, and stages of the disease, Monique Minnema, MD, PhD University Medical Center Utrecht, the Netherlands
	Myeloma related diseases, their presentation and effects on symptoms and quality of life, Paolo Milani, MD, PhD, University of Pavia, Pavia, Italy
	Moderated Q&A
10.45 – 11.00	Coffee break
11.00 – 12.30	Access to new treatments
	Immunotherapy in the treatment of myeloma and AL amyloidosis, Marivi Mateos
	A clinical perspective on access in central and eastern European and Balkan countries, Roman Hájek, M.D., Ph.D., University Hospital Ostrava, Czech Republic
	Moderated Q&A
12.30 – 13.30	Lunch break
13.30 – 15.00	Empowering Patient Organisations
	Palliative Care and quality of life, Christina Gerlach, M.D.
	Fundraising for patient groups and collaboration with industry, Jan Geissler, Chair, Workgroup of European Cancer Patient Advocacy Networks (WECAN)
15:00 – 15:15	Coffee Break
15.15 – 16.45	Panel discussion on Minimal Residual Disease (MRD)
	Hans Jacobs, M.D., Ph.D., Medical Immunologist, Radboud University Medical Center, NL
	Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) and member at the European Medicine Agency (EMA)
	Hans Scheurer, MPE President
16.45 – 17.00	Wrap up and close, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO